Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Hyperlipoproteinemia”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391722
What this trial is testing

DNV001 Injection in Patients With Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hangzhou Dinovate Biotech Co., Ltd 120
Large-scale testing (Phase 3)Looking for participantsNCT07421297
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 760
Large-scale testing (Phase 3)Looking for participantsNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT04516291
What this trial is testing

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Who this might be right for
DyslipidemiasHyperlipidemiasHyperlipoproteinemias
Pfizer 286
Large-scale testing (Phase 3)Study completedNCT00536510
What this trial is testing

Effect of MK0524A on Cholesterol Levels (0524A-048)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 646
Large-scale testing (Phase 3)Study completedNCT00269204
What this trial is testing

Lipid Efficacy/Tolerability Study (0524A-020)

Who this might be right for
Primary HypercholesterolaemiaMixed Hyperlipidaemia
Merck Sharp & Dohme LLC 1,620
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Early research (Phase 1)Study completedNCT02275156
What this trial is testing

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Amgen 18
Large-scale testing (Phase 3)Study completedNCT00289900
What this trial is testing

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Who this might be right for
Mixed Hyperlipidemia
Merck Sharp & Dohme LLC 2,340
Early research (Phase 1)Study completedNCT00565292
What this trial is testing

MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Ended earlyNCT00325455
What this trial is testing

MK0859 Dose-Ranging Study (0859-003)

Who this might be right for
HypercholesterolemiaMixed Hyperlipemia
Merck Sharp & Dohme LLC 500
Not applicableStudy completedNCT05087823
What this trial is testing

The Mixed Meal Challenge Study

Who this might be right for
Cardiovascular DiseasesHyperlipidemias
Emory University 11
Large-scale testing (Phase 3)Study completedNCT01854918
What this trial is testing

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemia and Mixed Dyslipidemia
Amgen 3,681
Testing effectiveness (Phase 2)Study completedNCT02008084
What this trial is testing

A Pilot Study to Evaluate the Lipid Effects of TRIA-662

Who this might be right for
HypertriglyceridemiaMixed Hyperlipidemia
Cortria Corporation 71
Post-approval studies (Phase 4)WithdrawnNCT02069106
What this trial is testing

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Who this might be right for
Mixed Hyperlipoproteinemia
Nordic Pharma, USA
Post-approval studies (Phase 4)Not Yet RecruitingNCT07674368
What this trial is testing

Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed

Who this might be right for
ALK Fusion-positive Non-small Cell Lung Cancer
Hunan Cancer Hospital 29
Large-scale testing (Phase 3)Study completedNCT04781114
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 806
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Large-scale testing (Phase 3)WithdrawnNCT02799758
What this trial is testing

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

Who this might be right for
HyperlipidemiaDyslipidemia
Kowa Research Institute, Inc.
Load More Results